Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Julianne Smith, Andrew M. Scharenberg et al.|Cancer Research|2015Cited by 600
Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cellsCécile Schiffer Mannioui, Andrew M. Scharenberg, Laëtitia Lemaire et al.|Journal for ImmunoTherapy of Cancer|2013Cited by 1
Supplementary Figures 1 - 5, Tables 1 - 3 from Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Julianne Smith, Brian Philip et al.|Unknown|2023Cited by 0
Data from Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Julianne Smith, Brian Philip et al.|Unknown|2023Cited by 0
Data from Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Julianne Smith, Brian Philip et al.|Unknown|2023Cited by 0